Kraftland Eagle Eye
Quarterly & annual financials, six-month news scan, R&D pipelines, hiring themes and CDSCO drug approvals across six Indian pharma majors — Sun Pharma, Dr Reddy's, Lupin, Wockhardt, Cipla and Torrent Pharma.
Announcements & news
Feb – Aug 2026Leadership changes, new therapy-area focus, new investment, and new drug launches from the last six months.
Pipeline
Company & third-party sources, pulled 18 Aug 2026Clinical-stage and recently-approved candidates by company — from each company's own pipeline page where published (Sun Pharma US Innovative Medicines, Dr Reddy's Biologics), Patsnap Synapse for Lupin, and public filings/news for Wockhardt, Cipla and Torrent Pharma where no single official pipeline page exists.
Revenue
₹ CrLast 8 quarters (Sep-24 → Jun-26) and last 3 financial years (FY24–FY26), consolidated sales.
Quarterly
Annual (FY)
View data table
EBITDA
₹ CrOperating profit (sales less operating expenses, before interest, depreciation & tax) — screener.in's "Operating Profit" line.
Quarterly
Annual (FY)
View data table
Net Profit
₹ CrProfit after tax, consolidated.
Quarterly
Annual (FY)
View data table
Margins
% of revenue, quarterlyEBITDA margin and net profit margin, last 8 quarters.
EBITDA margin
View data table
Net profit margin
View data table
EBITDA margin — change over last 6 quarters
Margin in each of the last 6 quarters, plus the point-change from the first to the last quarter shown.
Revenue growth — YoY
%Each quarter's revenue vs. the same quarter a year earlier, last 8 quarters. Labels appear on wider bars only — toggle companies off in the legend above to reveal more.
View data table
Annual revenue growth — YoY, last 3 financial years
Growth vs. the prior financial year, computed from FY2023–FY2026 revenue.
Hiring themes
Naukri.com, live, 18 Aug 2026Top job-department categories per company, from each company's own Naukri careers page (exact-employer match, not keyword search).
Cross-check: Monster / foundit.in keyword search
CDSCO drug approvals
cdscoonline.gov.in, live, 18 Aug 2026From companies tracked on this dashboard
All approvals in window ()
| Date | Type | Drug | Composition | Dosage | Indication | Manufacturer |
|---|
Type codes: ND = New Drug · SND = Subsequent New Drug · BIO = Biological · FDC = Fixed Dose Combination. Some composition/indication text is truncated at source. Source: cdscoonline.gov.in.
Kraftland Eagle Eye
Quarterly & annual financials, six-month news scan, R&D pipelines, hiring themes and CDSCO drug approvals across six Indian pharma majors — Sun Pharma, Dr Reddy’s, Lupin, Wockhardt, Cipla and Torrent Pharma.
Announcements & news
Feb – Aug 2026
Leadership changes, new therapy-area focus, new investment, and new drug launches from the last six months.
Pipeline
Company & third-party sources, pulled 18 Aug 2026
Clinical-stage and recently-approved candidates by company — from each company’s own pipeline page where published (Sun Pharma US Innovative Medicines, Dr Reddy’s Biologics), Patsnap Synapse for Lupin, and public filings/news for Wockhardt, Cipla and Torrent Pharma where no single official pipeline page exists.
Revenue
₹ Cr
Last 8 quarters (Sep-24 → Jun-26) and last 3 financial years (FY24–FY26), consolidated sales.
Quarterly
Annual (FY)
View data table
EBITDA
₹ Cr
Operating profit (sales less operating expenses, before interest, depreciation & tax) — screener.in’s “Operating Profit” line.
Quarterly
Annual (FY)
View data table
Net Profit
₹ Cr
Profit after tax, consolidated.
Quarterly
Annual (FY)
View data table
Margins
% of revenue, quarterly
EBITDA margin and net profit margin, last 8 quarters.
EBITDA margin
View data table
Net profit margin
View data table
EBITDA margin — change over last 6 quarters
Margin in each of the last 6 quarters, plus the point-change from the first to the last quarter shown.
Revenue growth — YoY
%
Each quarter’s revenue vs. the same quarter a year earlier, last 8 quarters. Labels appear on wider bars only — toggle companies off in the legend above to reveal more.
View data table
Annual revenue growth — YoY, last 3 financial years
Growth vs. the prior financial year, computed from FY2023–FY2026 revenue.
Hiring themes
Naukri.com, live, 18 Aug 2026
Top job-department categories per company, from each company’s own Naukri careers page (exact-employer match, not keyword search).
Cross-check: Monster / foundit.in keyword search
CDSCO drug approvals
cdscoonline.gov.in, live, 18 Aug 2026
From companies tracked on this dashboard
All approvals in window ()
| Date | Type | Drug | Composition | Dosage | Indication | Manufacturer |
|---|
Type codes: ND = New Drug · SND = Subsequent New Drug · BIO = Biological · FDC = Fixed Dose Combination. Some composition/indication text is truncated at source. Source: cdscoonline.gov.in.